Joy E. Koda

3.0k total citations
22 papers, 2.3k citations indexed

About

Joy E. Koda is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Surgery. According to data from OpenAlex, Joy E. Koda has authored 22 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Endocrine and Autonomic Systems and 6 papers in Surgery. Recurrent topics in Joy E. Koda's work include Regulation of Appetite and Obesity (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes Treatment and Management (5 papers). Joy E. Koda is often cited by papers focused on Regulation of Appetite and Obesity (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes Treatment and Management (5 papers). Joy E. Koda collaborates with scholars based in United States and China. Joy E. Koda's co-authors include Merton Bernfield, Alan C. Rapraeger, Christian Weyer, Jonathan D. Roth, James L. Trevaskis, David G. Parkes, Markku Jalkanen, Rebecca L. Cole, Alain Baron and Kevin Beaumont and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Radiology.

In The Last Decade

Joy E. Koda

22 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy E. Koda United States 19 746 680 616 583 452 22 2.3k
Roman Muff Switzerland 34 2.2k 2.9× 175 0.3× 338 0.5× 172 0.3× 464 1.0× 95 3.3k
Mayumi Inoue Japan 26 1.4k 1.9× 59 0.1× 527 0.9× 445 0.8× 191 0.4× 53 2.7k
Nahid Waleh United States 29 995 1.3× 315 0.5× 159 0.3× 269 0.5× 26 0.1× 62 2.5k
Sandra E. Guggino United States 35 1.8k 2.4× 133 0.2× 269 0.4× 218 0.4× 138 0.3× 79 2.9k
Parth Patwari United States 26 1.1k 1.5× 46 0.1× 467 0.8× 502 0.9× 108 0.2× 41 2.8k
Didier Communi Belgium 31 1.6k 2.2× 487 0.7× 497 0.8× 56 0.1× 61 0.1× 61 3.8k
Thomas Voït Germany 40 3.5k 4.6× 117 0.2× 1.0k 1.7× 393 0.7× 113 0.3× 136 5.3k
G. Properzi Italy 25 1.1k 1.4× 45 0.1× 313 0.5× 338 0.6× 127 0.3× 48 2.2k
Eva Cernuda‐Morollón Spain 26 1.2k 1.6× 133 0.2× 504 0.8× 138 0.2× 30 0.1× 42 2.9k
Kim S. Lau United States 28 1.6k 2.1× 153 0.2× 1.2k 1.9× 455 0.8× 74 0.2× 43 2.9k

Countries citing papers authored by Joy E. Koda

Since Specialization
Citations

This map shows the geographic impact of Joy E. Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy E. Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy E. Koda more than expected).

Fields of papers citing papers by Joy E. Koda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy E. Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy E. Koda. The network helps show where Joy E. Koda may publish in the future.

Co-authorship network of co-authors of Joy E. Koda

This figure shows the co-authorship network connecting the top 25 collaborators of Joy E. Koda. A scholar is included among the top collaborators of Joy E. Koda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy E. Koda. Joy E. Koda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Jean L., Joy E. Koda, Joseph S. Heilig, et al.. (2015). Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy. Clinical Endocrinology. 85(1). 137–149. 56 indexed citations
2.
Trevaskis, James L., Chunli Lei, Joy E. Koda, et al.. (2009). Interaction of Leptin and Amylin in the Long‐term Maintenance of Weight Loss in Diet‐induced Obese Rats. Obesity. 18(1). 21–26. 79 indexed citations
3.
Ravussin, Éric, Steven R. Smith, Julie A. Mitchell, et al.. (2009). Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy. Obesity. 17(9). 1736–1743. 259 indexed citations
4.
Trevaskis, James L., Todd Coffey, Rebecca L. Cole, et al.. (2008). Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms. Endocrinology. 149(11). 5679–5687. 125 indexed citations
5.
Roth, Jonathan D., Barbara Roland, Rebecca L. Cole, et al.. (2008). Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies. Proceedings of the National Academy of Sciences. 105(20). 7257–7262. 348 indexed citations
6.
7.
Fineman, Mark, Joy E. Koda, S. Strobel, et al.. (2002). The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. Metabolism. 51(5). 636–641. 103 indexed citations
8.
Rudge, Scott R., et al.. (2001). Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). Journal of Controlled Release. 74(1-3). 335–340. 105 indexed citations
9.
Vine, William, et al.. (1998). Plasma Amylin Concentrations in Fasted and Fed Rats Quantified by a Monoclonal Immunoenzymometric Assay. Hormone and Metabolic Research. 30(9). 581–585. 12 indexed citations
10.
Colburn, Wayne A., Alan Gottlieb, Joy E. Koda, & Orville Kolterman. (1996). Pharmacokinetics and Pharmacodynamics of AC137 (25,28,29 Tripro‐Amylin, Human) After Intravenous Bolus and Infusion Doses in Patients with Insulin‐Dependent Diabetes. The Journal of Clinical Pharmacology. 36(1). 13–24. 46 indexed citations
11.
Young, Andrew A., William Vine, Bronislava Gedulin, et al.. (1996). Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Development Research. 37(4). 231–248. 1 indexed citations
12.
Dimsdale, Joel E., Orville Kolterman, Joy E. Koda, & Richard A. Nelesen. (1996). Effect of Race and Hypertension on Plasma Amylin Concentrations. Hypertension. 27(6). 1273–1276. 15 indexed citations
13.
Young, Andrew A., William Vine, Bronislava Gedulin, et al.. (1996). Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Development Research. 37(4). 231–248. 109 indexed citations
14.
Pittner, Richard, K Albrandt, Kevin Beaumont, et al.. (1994). Molecular physiology of amylin. Journal of Cellular Biochemistry. 55(S1994A). 19–28. 80 indexed citations
15.
Rink, T J, Kevin Beaumont, Joy E. Koda, & Andrew W. Young. (1993). Structure and biology of amylin. Trends in Pharmacological Sciences. 14(4). 113–118. 83 indexed citations
16.
Young, Andrew A., et al.. (1992). Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats.. Hypertension. 19(1_supplement). I101–9. 40 indexed citations
17.
Bray, Kurtis R., Joy E. Koda, & Praveen Kumar Gaur. (1987). Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.. PubMed. 47(22). 5853–60. 38 indexed citations
18.
Rapraeger, Alan C., et al.. (1985). The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans.. Journal of Biological Chemistry. 260(20). 11046–11052. 251 indexed citations
19.
Koda, Joy E. & Merton Bernfield. (1984). Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils.. Journal of Biological Chemistry. 259(19). 11763–11770. 102 indexed citations
20.
Bernfield, Merton, Shib D. Banerjee, Joy E. Koda, & Alan C. Rapraeger. (1984). Remodelling of the Basement Membrane: Morphogenesis and Maturation. Novartis Foundation symposium. 108. 179–196. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roman Muff Breakdown of academic impact, for papers by Mayumi Inoue Breakdown of academic impact, for papers by Nahid Waleh Breakdown of academic impact, for papers by Sandra E. Guggino Breakdown of academic impact, for papers by Parth Patwari Breakdown of academic impact, for papers by Didier Communi Breakdown of academic impact, for papers by Thomas Voït Breakdown of academic impact, for papers by G. Properzi Breakdown of academic impact, for papers by Eva Cernuda‐Morollón Breakdown of academic impact, for papers by Kim S. Lau
Rankless by CCL
2026